Neuropeptide Y (22-36), a 15 amino acid peptide, is a fragment of Neuropeptide Y.
Neuropeptide Y 22-36 is a synthetic peptide fragment corresponding to amino acid residues 22 through 36 of the full-length Neuropeptide Y (NPY), a widely studied neurotransmitter involved in numerous physiological processes within the central and peripheral nervous systems. As a truncated analog of NPY, this peptide retains specific receptor interaction domains, making it a valuable tool for dissecting the structure-function relationships of NPY and its receptor subtypes. Its unique sequence and biological relevance have positioned it as an important reagent in neurobiological research, particularly in studies focused on receptor binding, peptide signaling pathways, and neurochemical modulation.
Receptor Binding Studies: Neuropeptide Y 22-36 is frequently utilized in receptor pharmacology to delineate the binding preferences and activation profiles of NPY receptor subtypes, particularly Y2 and Y5. By employing this fragment in competitive binding assays or functional response measurements, researchers can investigate how the C-terminal region of NPY contributes to selective receptor activation, affinity, and downstream signaling. Such studies are crucial for mapping receptor-ligand interactions and for identifying potential allosteric sites or modulatory regions within the NPY receptor family.
Peptide Structure-Activity Relationship (SAR) Analysis: The use of NPY 22-36 enables detailed structure-activity relationship investigations, allowing scientists to pinpoint which amino acid residues are critical for biological activity. By comparing the functional properties of this fragment to those of full-length NPY and other truncated analogs, researchers can elucidate the minimal sequence requirements for receptor engagement and signal transduction. These SAR studies inform the rational design of novel peptide analogs with tailored bioactivity for research or screening applications.
Neurochemical Pathway Elucidation: In neurobiology, NPY 22-36 serves as a selective probe to dissect the roles of NPY-derived peptides in modulating neurotransmitter release, synaptic plasticity, and neuronal excitability. Its application in in vitro and ex vivo systems, such as brain slice preparations or primary neuronal cultures, allows for the targeted analysis of peptide-mediated effects on neural circuits. This approach is instrumental in clarifying the distinct contributions of NPY fragments to neurochemical regulation beyond those of the full-length peptide.
Peptide Receptor Antagonism and Agonism Studies: As a C-terminal fragment, NPY 22-36 may act as a partial agonist or antagonist at certain NPY receptor subtypes, depending on the experimental context. Researchers leverage this property to investigate competitive inhibition or partial activation mechanisms, which are essential for understanding the nuances of receptor modulation. Such studies can reveal how truncated peptides influence endogenous NPY signaling, offering insights into receptor desensitization, internalization, and cross-talk with other neurotransmitter systems.
Peptide Synthesis and Analytical Method Development: NPY 22-36 is also employed as a reference standard or calibration peptide in peptide synthesis optimization and analytical method validation. Its defined sequence and physicochemical properties make it suitable for evaluating chromatographic separation techniques, mass spectrometric detection, and peptide quantification protocols. These applications support the advancement of peptide chemistry workflows and ensure the reliability of peptide-based assays in neurobiological research.
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More